Skip to content

The Effects of an Integrated Mindfulness-based Tai Chi Chuan Program on Sleep Disturbance Among Community-dwelling Elderly People

The Effects of an Integrated Mindfulness-based Tai Chi Chuan Program on Sleep Disturbance Among Community-dwelling Elderly People: A Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05396092
Acronym
MBTCC
Enrollment
256
Registered
2022-05-31
Start date
2022-04-19
Completion date
2025-04-18
Last updated
2022-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly, Mindfulness, Sleep, Tai Chi Chuan

Brief summary

The trial aims to evaluate the effects of an integrated form of mindfulness-based Tai Chi Chuan (MBTCC) program and the underlying mechanisms of the beneficial effects on sleep disturbance over 12-month follow-up in community-dwelling elderly people.

Interventions

BEHAVIORALIntegrated mindfulness-based Tai Chi Chuan

MBTCC will integrate components from both the MBI and TCC groups. The entire intervention consists of eight weekly sessions of two-and-a-half to three hours each.

BEHAVIORALMindfulness-based intervention

The MBI group is mainly based on the basic theory and research of the foundational mindfulness-based stress reduction program. The intervention consists of eight weekly sessions of two to two-and-a-half hours each.

BEHAVIORALTai Chi Chuan

TCC is mainly based on a nine-form Yang-style form of TCC, which is a brief and modified version of 64-form Yang-style TCC. The entire intervention consists of eight weekly sessions of two to two-and-a-half hours each.

BEHAVIORALSleep Hygiene Education

SHE is based on principles used in stimulus control and sleep hygiene education, which has previously been used as the control group in sleep-related research. The entire intervention consists of eight weekly sessions of two to two-and-a-half hours each.

Sponsors

Food and Health Bureau, Hong Kong
CollaboratorOTHER_GOV
The Hong Kong Polytechnic University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Aged 60 years or above; * Classified as experiencing sleep disturbances (indication of poor sleep quality through a score \>5 in the Pittsburgh Sleep Quality Index); * Primary education level or above and able to communicate in Cantonese; * Able to give informed consent; and * No previous experience with meditation or other mind-body techniques (e.g., tai chi or yoga).

Exclusion criteria

• Comorbid diagnoses of schizophrenia, schizoaffective disorder, substance misuse, organic brain syndrome, or intellectual disabilities.

Design outcomes

Primary

MeasureTime frameDescription
the Insomnia Severity Indexat baseline (T1)This is a seven-item self-report questionnaire. A higher score represents greater insomnia severity.

Secondary

MeasureTime frameDescription
the Multidimensional Assessment of Interoceptive Awareness scaleat baseline (T1)The scale consists of 32 items and comprises eight subscales. A higher score indicates higher levels of interoceptive awareness.
Wrist ActiGraph GT9X (ActiGraph, Pensacola, USA)at baseline (T1)Participants will be asked to put on this ActiGraph GT9X (like a watch) on the wrist of the non-dominant hand for one week. Wrist ActiGraph GT9X is used to assess the average total sleep time (hours) per night.

Other

MeasureTime frameDescription
the Chinese (Hong Kong) Short-Form-12at baseline (T1)A higher respective summary score indicates better levels of health.
the rumination subscale from the Rumination-Reflection Questionnaireat baseline (T1)A higher score suggests greater ruminative tendencies.
the hyperarousal scaleat baseline (T1)A higher score suggests a higher arousal level.

Countries

Hong Kong

Contacts

Primary ContactShu-Mei Wang, PhD
shumei.wang@polyu.edu.hk852-27664197

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026